Amylyx Share Price

Amylyx Share Price

NASDAQ: AMLX | Mid Cap | Healthcare
$26.03
-$0.11 (-0.44%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Amylyx Stock Performance

Open
$25.87
Prev. Close
$26.14
Circuit Range
N/A
Day Range
$25.73 - $26.36
Year Range
$10.85 - $40.42
Volume
60,316
Average Traded
$26.06

Amylyx Share Price Today

As of 21 November 2026, Amylyx Pharmaceuticals, Inc.'s share price is $26.03. The stock opened at $25.87, compared to its previous close of $26.14. During today's trading session, Amylyx Pharmaceuticals, Inc.'s share price traded between $25.73 and $26.36, with an average price of $26.05. Over the past 52 weeks, the stock has recorded a high of $40.42 and a low of $10.85. In terms of performance, Amylyx Pharmaceuticals, Inc.'s share price has risen by 81.14% over the last six months and is up 73.88% on a year-on-year basis.

Amylyx Share Price Chart

Line chart of the Amylyx price trend over the selected period. The price fell overall, ranging from 25.65 to 26.36, ending at 26.01.
$25.73$26.36
L
Show Current Price
H

Amylyx Stock Fundamentals & Key Indicators

Market Cap
$2.46B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
-21.65%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-37.85%

Amylyx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$33.00-$41.28-$43.42-$45.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-25.09%-5.18%-4.77%

Amylyx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$22.23$380.79$87.37$0.00
Net Profit-$198.38$49.27-$301.74-$144.74
Net Profit Margin-892.40%12.94%-345.36%N/A
Income ChangeN/A124.84%-712.42%52.03%

Amylyx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets8.974.252.799.32
Current Assets323.67189.43464.67382.13
Total Assets332.65193.63517.45391.45
Non Current Liabilities4.70.461.984.24
Current Liabilities22.6928.4182.0446.61
Total Liabilities27.3928.8784.0250.85
Shareholders' Equity305.26164.77433.43340.61

Amylyx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-123.34-167.6511.92-179.87
Investing14.0475.6592.05-238.99
Financing257.030.353.54431.79

About Amylyx

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Amylyx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$29.02
$25.98
-10.01%
Oct 2026
$28.66
$28.88
-0.98%
Sep 2026
$33.86
$29.16
-21.57%
Aug 2026
$20.00
$37.18
+82.88%
Jul 2026
$17.72
$20.33
+13.16%
Jun 2026
$14.02
$17.96
+25.02%
May 2026
$16.11
$14.37
-10.13%
Apr 2026
$14.02
$15.99
+15.04%
Mar 2026
$15.36
$13.90
-8.49%
Feb 2026
$14.29
$15.19
+6.30%
Jan 2026
$11.98
$14.29
+18.20%
Dec 2025
$14.58
$12.09
-19.24%

Amylyx Share Price FAQs